Summary & Overview
Acute Leukemia with Complication or Comorbidity: Inpatient Reimbursement Overview
DRG 835 encompasses acute leukemia admissions with Complication or Comorbidity and signals higher resource needs than non-Complication or Comorbidity cases. Clinical scope includes induction therapy, transfusion support, infection management, and treatment-related complications, which influence Medicare inpatient reimbursement classification.
DRG 835 Overview
DRG 835 covers inpatient admissions for acute leukemia when Complication or Comorbidity are present, including cases of newly diagnosed or relapsed acute myeloid or acute lymphoblastic leukemias that require hospitalization for initial therapy, transfusions, infection management, or treatment complications. This Diagnosis-Related Group groups patients by clinical severity to determine Medicare payment relative to other leukemia admissions. The presence of a Complication or Comorbidity increases resource use and affects relative reimbursement compared with non-Complication or Comorbidity cases. Understanding this allocation is important for accurate inpatient coding and payment classification.